IPO Investing in India: Mainboard, SME, and Pre-IPO Unlisted Shares
IPO investing means applying for shares when a company lists on the BSE or NSE for the first time, through the ASBA process, while pre-IPO investing means buying unlisted shares in a private company before it lists; both carry real risk: allotment in an oversubscribed IPO is never assured, listing performance is never assured, and how one IPO or one year performed does not predict how the next one will.
How Applications Are Processed
What Is IPO Investing, and What Does It Cover?
IPO investing covers two distinct categories. The first is mainboard and SME IPOs: applying for shares when a company lists on the BSE or NSE for the first time, using the ASBA (Application Supported by Blocked Amount) process through your Demat account, typically via a UPI mandate. Funds are blocked in your bank account, not debited, until allotment is confirmed; if you are not allotted shares, the block is released. In an oversubscribed issue, allotment for retail investors is lottery-based: applying does not mean you will receive shares, and there is no way to improve your odds beyond applying correctly.
The second category is pre-IPO and unlisted shares: purchasing equity in a private company before it lists, through an off-market, negotiated transaction rather than an exchange. Sources include employee ESOP holdings, promoter or early-investor stakes, and direct placements. Talk2Invest supports both categories, always within the context of your broader portfolio rather than as a standalone transaction.
Allotment in an oversubscribed IPO is never guaranteed: it's decided by lottery. Listing performance is never guaranteed either: a stock can list below its issue price as easily as above it. Past IPO cycles do not predict any specific future IPO.
How to Apply for IPOs in India: The Process
The ASBA (Application Supported by Blocked Amount) process is straightforward once you know the steps. Funds are blocked in your bank account, not debited, until allotment is confirmed.
GMP is the premium at which IPO shares trade in the unofficial grey market before official listing. It is a sentiment indicator, not a legally recognised price, and can shift sharply in the final 48 hours before listing. Our team treats GMP as one data point alongside subscription figures, issue quality, and category demand, never as a promise of listing gains.
Our team helps with application guidance, category selection (retail/HNI/QIB), and timing across IPO subscription windows.
Get IPO Application GuidancePre-IPO and Unlisted Shares: Accessing Companies Before They List
Unlisted shares are equity shares of private companies traded off-market between buyers and sellers, outside the BSE or NSE. Sources include employee ESOP holdings, promoter or early-investor stakes, and direct placements.
Pricing is over-the-counter and negotiated between parties. There is no regulated exchange, so price discovery is imperfect. Talk2Invest supports clients through pre-IPO opportunities with full counterparty documentation reviewed before any transaction.
View wealth management servicesPre-IPO exposure to companies before retail investors can participate in the open market: access, not a guaranteed outcome.
Bought directly from an existing holder (ESOP, promoter, or early investor) at a mutually agreed price, rather than through an exchange order book.
Exit before listing depends entirely on finding a willing buyer. There is no market-maker and no guaranteed timeline.
Unlike exchange-traded shares, there is no regulatory oversight of OTC pricing. Overvaluation is a genuine risk.
Risks Investors Must Understand Before Committing Capital
SEBI has mandated a T+3 working day listing timeline since December 2023: a mainboard or SME IPO's shares list on the exchange within 3 working days of the issue closing. This replaced the longer listing timelines used in earlier years, so if you're recalling an older, longer figure from a few years back, it no longer applies. Because ASBA/UPI funds are only blocked, not debited, the release of blocked funds for unsuccessful applicants happens within this same T+3 cycle; if an issuer fails to complete refunds within SEBI's prescribed timeline, it owes investors 15% p.a. interest on the delayed amount.
Allotment Is Never Guaranteed
In an oversubscribed mainboard or SME IPO, allotment for retail investors is lottery-based. Applying in full does not mean receiving shares.
Listing Performance Is Never Guaranteed
A stock can list below its issue price as easily as above it. How past IPOs performed does not predict how any future IPO will perform.
6-Month Post-Listing Lock-In
Under SEBI regulation, pre-IPO allottees face a mandatory 6-month lock-in from the listing date. Shares cannot be sold on the exchange during this window.
Liquidity Risk Before Listing
There is no exchange to sell on before listing. Exit depends on locating a buyer, and the timeline to listing can extend, stall, or the IPO can be shelved.
Valuation Risk
OTC prices are unregulated and can trade at a premium to fundamental value. Buying above a justified valuation erodes returns even if the IPO eventually lists.
Limited Regulatory Protection
Unlike BSE/NSE trades, OTC deals have more limited grievance mechanisms. Proper documentation and counterparty verification are the primary safeguards.
Anchor investors (institutions allotted shares a day before the issue opens to the public) are subject to a separate lock-in: 50% of their anchor shares are locked in for 30 days from allotment, and the remaining 50% for 90 days. This structure is unchanged and still current. It mainly affects anchor-investor selling pressure around specific post-listing dates rather than affecting how retail applications work.
How Pre-IPO Investments Fit Into a Portfolio
These risks are real and should factor into any decision before money moves. Allotment in a mainboard or SME IPO is never assured: applying in full does not mean receiving an allotment, particularly in an oversubscribed issue. Listing performance is not assured either: a stock can list below its issue price as easily as above it, and how past IPOs performed on listing day, in any given year, does not predict how any specific future IPO will perform.
Pre-IPO and unlisted shares carry additional risk. Under SEBI regulation, pre-IPO allottees face a mandatory 6-month lock-in from the listing date, during which shares cannot be sold on the exchange. Before listing, there is no exchange to sell on at all: an exit depends entirely on finding a willing buyer, and the timeline to listing can extend, stall, or the IPO can be shelved altogether. OTC pricing is unregulated, which means overvaluation is a genuine risk, and grievance mechanisms are more limited than for exchange-traded shares. Proper documentation and a considered review of the opportunity are the primary safeguards available to an investor in this space.
Review Your Portfolio FitInterested in an IPO or Pre-IPO Opportunity?
Our team reviews fundamentals and portfolio fit before any unlisted share opportunity is brought to a client. No opportunity is suggested without a due diligence review and allocation analysis specific to your situation.
Book a Free* GuidanceWhat We Look for When Evaluating a Pre-IPO Opportunity
Every pre-IPO opportunity goes through a structured review before it reaches a client. Here is the checklist we apply.
Company Fundamentals
Revenue growth trajectory, profitability trend (EBITDA margin), and net debt levels are reviewed before any pre-IPO opportunity reaches a client.
Promoter Track Record
Management history and governance record. Who runs the company is reviewed alongside the financials.
Sector Tailwinds
Total addressable market and structural demand trends, since pre-IPO positions require a multi-year view.
DRHP Filed with SEBI
A filed Draft Red Herring Prospectus signals the listing is closer and financials are publicly available: the most reliable signal available.
Valuation vs. Listed Peers
Whether the OTC price sits at a discount or premium to comparable listed companies' multiples.
Exit Visibility
How concrete the listing timeline is. Vague timelines carry meaningfully higher risk than a filed, SEBI-reviewed DRHP.
Tax Treatment on IPO and Pre-IPO Gains
Capital gains tax rates as currently in force: figures reflect tax law, not a projection of what any investment will return. Confirm your specific situation with a chartered accountant.
| Investment Type | Holding Period | Gain Type | Tax Rate |
|---|---|---|---|
| Listed shares (post-IPO) | Under 12 months | Short-term capital gain | 20% |
| Listed shares (post-IPO) | Over 12 months | Long-term capital gain | 12.5% above ₹1.25L |
| Unlisted shares (pre-listing sale) | Under 24 months | Short-term (unlisted) | As per slab rate |
| Unlisted shares (pre-listing sale) | Over 24 months | Long-term (unlisted) | 12.5% (no indexation) |
Individual tax situations vary. Verify with a qualified chartered accountant before filing.
Our Team's Credentials
AMFI MF Distributor (2823) & MF/SIF Distributor (300788)
CFP Certification, FPSB India
MDRT (6x): Rekha Guliani
LUTCF, The American College of Insurance
Chairman Club, ICICI Prudential MF
Frequently Asked Questions
Direct answers to the questions we hear most often. No hedging, no ambiguity.
Contact for specific questionsNo. In an oversubscribed issue, allotment for retail investors is decided by lottery. Applying correctly and in full does not assure you will receive shares: many applicants in a popular IPO receive no allotment at all, and their blocked funds are simply released.
No. Listing-day performance varies significantly by issue, sector, and market conditions at the time. 2025 was a record year for mainboard IPO volume (roughly 108 issues raising around ₹1,83,432 crore), yet the median listing-day gain across those issues moderated to about 3.8%, and the average cooled further to roughly 1.6-1.7% in H1 2026. That trend itself is just descriptive history, not a predictor: some issues list below their issue price in any market environment. Each application should be evaluated on its own fundamentals, not on how other IPOs recently performed.
SEBI has mandated a T+3 working day listing timeline since December 2023: shares list within 3 working days of the issue closing. This applies to mainboard and SME IPOs alike, and replaced the longer listing timelines used in earlier years. If your blocked ASBA/UPI funds aren't allotted shares, the block is released within this same T+3 cycle.
Under SEBI regulation, shares acquired through a pre-IPO placement are subject to a mandatory 6-month lock-in from the date of listing. You cannot sell on the exchange during this window, so liquidity needs should be planned around this before committing funds.
They're bought off-market, through negotiated transactions with a seller (typically an ESOP holder, promoter, or early investor) followed by a share transfer agreement and an off-market Demat transfer. There is no exchange involved, so counterparty verification and proper documentation matter more than in a standard exchange trade.
Listed shares sold within 12 months of listing are taxed at 20% as short-term capital gains; sold after 12 months, at 12.5% above a ₹1.25 lakh annual exemption as long-term gains. Unlisted shares sold before listing are taxed at your income slab rate if held under 24 months, or at 12.5% without indexation if held over 24 months. Confirm your specific situation with a chartered accountant.
As a tactical allocation, typically 5-10% of an equity portfolio, suited to investors with a 3-5 year horizon and genuine tolerance for illiquidity and loss. This should sit alongside, not instead of, core equity mutual fund holdings, and only after retirement and insurance planning are already in place.
Considering an IPO or Pre-IPO Opportunity?
Talk to our team before committing capital; we review fundamentals and portfolio fit first.
A member of our team will confirm a time within one business day.
We do not charge anything for the guidance we provide. For any investments made through us, the AMCs may pay us a commission. Our recommendations are based on your risk profile, time horizon, and financial requirement, not on the commission we may earn.